SPL — Starpharma Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- AU$169.38m
- AU$156.38m
- AU$5.85m
- 38
- 19
- 96
- 51
Annual cashflow statement for Starpharma Holdings, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 7.46 | 8.33 | 8.34 | 8.78 | 6.5 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -14.8 | -13.2 | -13.5 | -6.98 | -6.76 |
| Capital Expenditures | -0.246 | -0.837 | -0.621 | -0.089 | -0.042 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.001 | 0.011 | 0 | — |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.246 | -0.836 | -0.61 | -0.089 | -0.042 |
| Financing Cash Flow Items | -1.93 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 46.3 | 3.23 | -0.695 | -4.75 | -1.13 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 30.4 | -10.6 | -14.7 | -11.8 | -7.95 |